IsoBio, Inc., 2025-11-14
An SEC Form D private-offering notice from Gladwyne, PA, a $3,000,000 filer-stated offering target in Biotech. Filed 2025-11-14. The source filing is one click away. For companies that filed this week, open the live feed.
What this filing says
Develops antibody-isotope conjugates, radiolabeled antibody therapeutics using isotopes such as Lutetium-177 and Actinium-225, for cancer treatment.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- LifeLens Technologies, Inc., 2025-11-17, $40M, Ivyland, PA
- Cellens, Inc., 2025-11-14, $6.4M, Boston, MA
- Philadelphia Whiskey Co., 2025-11-17, $200K, Philadelphia, PA
- Model Medicines, Inc., 2025-11-14, $5M, San Deigo, CA
- NEUROPATHIX, INC., 2025-11-17, $50M, Doylestown, PA
- FEMASYS INC, 2025-11-14, $12M, Suwanee, GA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.